Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that nearly 30 clinical studies of its globally first-in-class ...
Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of ...
Integrating the discussions from all six chapters of this book, we will organize a Japanese summary and an English abstract so that they can be used for book introductions, papers, and research ...
Leaps' from the Perspective of Informational Epistemology and the Continuity of Life and Consciousness〉1. Humans do not ...
If a machine can name the disease but still cannot be trusted to find it, what exactly have we bought? That is the awkward question hanging over medical AI: dazzling in the ...
The Phase 2 trial of ABCL635 (NCT07118891) is a multicenter, randomized, double-blind, placebo-controlled trial in ...
The ancient Egyptians built the pyramids with a height-to-base ratio of 1:1.618 — the Golden Ratio. The ancient Athenians, those masters of architecture, built the Parthenon with its column ...
In a metaphorical sense, the newspaper is like a second skin. It absorbs the morning reader’s reactions. It absorbs his ...
Wassily Kandinsky was a master of abstract art. Now, a new exhibition of more than 70 paintings at Rome's Palazzo Bonaparte explores the world he created and how the Russian artist became widely regar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results